You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • THU0363 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD) AND NORMAL VERSUS ELEVATED C-REACTIVE PROTEIN (CRP) AT BASELINE: ANALYSES FROM THE SENSCIS TRIAL

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Thursday, 04 June 2020
Scleroderma, myositis and related syndromes
THU0363 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD) AND NORMAL VERSUS ELEVATED C-REACTIVE PROTEIN (CRP) AT BASELINE: ANALYSES FROM THE SENSCIS TRIAL

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 202062012
Jul 20205207
Aug 20204500
Sep 20201406
Oct 20202203
Nov 20202005
Dec 20201601
Jan 20213200
Feb 20211806
Mar 20213002
Apr 20211402
May 2021502
Jun 2021002
Oct 20211900
Nov 20211300
Dec 20211500
Jan 2022500
Feb 2022500
Mar 20222203
Apr 20221300
May 20223100
Jun 20222201
Jul 20221800
Aug 20222800
Sep 20221202
Oct 20223101
Nov 20221501
Dec 20222101
Jan 20231200
Feb 20232900
Mar 2023901
Apr 20231702
May 20231300
Jun 2023601
Jul 20232300
Aug 20231000
Sep 20231700
Oct 20231200
Nov 20231700
Dec 20231500
Jan 20243200
Feb 2024800
Mar 20241200
Total832061